Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1430629

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1430629

Europe & Middle East Heparin Market - Industry Trends and Forecast to 2031

PUBLISHED:
PAGES: 268 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

The Europe and Middle East heparin market is expected to reach USD 3,794,707.9 thousand by 2031 from USD 2,444,237.3 thousand in 2024, growing at a CAGR of 5.7% in the forecast period of 2024 to 2031.

Market Segmentation:

Europe and Middle East Heparin Market, By Product Type (Low Molecular Weight Heparin (LMWH) and Unfractionated Heparin), Product (Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine, and Others), Mode of Administration (Subcutaneous, Intravenous, and Others), Packaging (10000 Unit, 25000 Unit, 5000 Unit, 1000 Unit, 100 Unit, 10 Unit, and Others), Source (Biological and Synthetic), Indication (Deep Vein Thrombosis, Pulmonary Embolism, Peripheral Artery Disease, Arterial thromboembolism, Myocardial Infarction, Atrial Fibrillation, and Others), Type (Generics and Branded), Container Type (Vials, Bags, Bottles, and Others), Packaging Material (Glass and Plastic), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy & Drug Store, Online Pharmacy, and Others), Country (Germany, France, U.K., Italy, Spain, Switzerland, Austria, Poland, Turkey, Belgium, Malta, Romania, Czech Republic, Ireland, Portugal, Norway, Greece, Bulgaria, Slovakia, Cyprus, Estonia, Latvia, Croatia, Bosnia & Herzegovina, Rest of Europe, Saudi Arabia) - Industry Trends and Forecast to 2031.

Overview Europe and Middle East Heparin Market Dynamics

Drivers

Increasing research and development activities

Restraint

Increasing government restriction

Opportunity

Growing healthcare expenditure

Market Players

Some major companies dealing in the Europe and Middle East heparin market are:

  • Bioiberica S.A.U. (Spain)
  • Opocrin S.p.A. (Italy)
  • Eisai Co., Ltd. (Japan)
  • LABORATORIOS FARMACEUTICOS ROVI SA (Spain)
  • ITALFARMACO S.p.A. (Italy)
  • Sanofi (France)
  • LEO Pharma A/S (Denmark)
  • Merck KGaA (U.S.)
  • Hepac (Netherlands)

TABLE OF CONTENTS

1 INTRODUCTION 30

  • 1.1 OBJECTIVES OF THE STUDY 30
  • 1.2 MARKET DEFINITION 30
  • 1.3 OVERVIEW OF THE EUROPE AND MIDDLE EAST HEPARIN MARKET 30
  • 1.4 CURRENCY AND PRICING 32
  • 1.5 LIMITATIONS 32
  • 1.6 MARKETS COVERED 32

2 MARKET SEGMENTATION 35

  • 2.1 MARKETS COVERED 35
  • 2.2 GEOGRAPHICAL SCOPE 36
  • 2.3 YEARS CONSIDERED FOR THE STUDY 36
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 37
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 40
  • 2.6 MULTIVARIATE MODELLING 41
  • 2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE 41
  • 2.8 MARKET END USER COVERAGE GRID 42
  • 2.9 DBMR MARKET POSITION GRID 43
  • 2.10 VENDOR SHARE ANALYSIS 44
  • 2.11 SECONDARY SOURCES 45
  • 2.12 ASSUMPTIONS 45

3 EXECUTIVE SUMMARY 46

4 PREMIUM INSIGHTS 49

  • 4.1 PESTAL ANALYSIS 50
  • 4.2 PORTERS FIVE FORCES 51

5 REGULATORY FRAMEWORK 52

6 MARKET OVERVIEW 54

  • 6.1 DRIVERS 56
    • 6.1.1 RISING PREVALENCE OF VENOUS THROMBOEMBOLISM AND PULMONARY EMBOLISM 56
    • 6.1.2 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES 56
    • 6.1.3 NEW POTENTIAL INDICATIONS FOR HEPARIN USE 57
    • 6.1.4 INCREASING DEMAND FOR ANTICOAGULANTS 57
  • 6.2 RESTRAINTS 58
    • 6.2.1 INCREASING GOVERNMENT RESTRICTION 58
    • 6.2.2 INCREASING PRODUCT RECALLS 58
  • 6.3 OPPORTUNITIES 59
    • 6.3.1 GROWING HEALTHCARE EXPENDITURE 59
    • 6.3.2 INCREASING DEVELOPMENTS IN BIOENGINEERING 59
    • 6.3.3 INCREASING DEMAND FOR BIOSIMILARS AND GENERICS 60
  • 6.4 CHALLENGES 60
    • 6.4.1 HIGH COMPETITION AMONG MARKET PLAYERS 60
    • 6.4.2 AVAILABILITY OF SUBSTITUTES 60

7 EUROPE & MIDDLE EAST HEPARIN MARKET, BY PRODUCT TYPE 62

  • 7.1 OVERVIEW 63
  • 7.2 LOW MOLECULAR WEIGHT HEPARIN (LMWH) 66
    • 7.2.1 ENOXAPARIN 66
    • 7.2.2 DALTEPARIN 66
    • 7.2.3 TINZAPARIN 67
    • 7.2.4 FRAXIPARINE 67
    • 7.2.5 OTHERS 67
  • 7.3 UNFRACTIONATED HEPARIN 67

8 EUROPE & MIDDLE EAST HEPARIN MARKET, BY MODE OF ADMINISTRATION 68

  • 8.1 OVERVIEW 69
  • 8.2 SUBCUTANEOUS 72
  • 8.3 INTRAVENOUS 72
  • 8.4 OTHERS 72

9 EUROPE & MIDDLE EAST HEPARIN MARKET, BY PACKAGING 73

  • 9.1 OVERVIEW 74
  • 9.2 10000 UNIT 77
  • 9.3 25000 UNIT 77
  • 9.4 5000 UNIT 77
  • 9.5 1000 UNIT 77
  • 9.6 100 UNIT 77
  • 9.7 10 UNIT 77
  • 9.8 OTHERS 78

10 EUROPE & MIDDLE EAST HEPARIN MARKET, BY SOURCE 79

  • 10.1 OVERVIEW 80
  • 10.2 BIOLOGICAL 83
  • 10.3 SYNTHETIC 83 

11 EUROPE & MIDDLE EAST HEPARIN MARKET, BY CONTAINER TYPE 84

  • 11.1 OVERVIEW 85
  • 11.2 VIALS 88
  • 11.3 BAGS 88
  • 11.4 BOTTLES 88
  • 11.5 OTHERS 88

12 EUROPE & MIDDLE EAST HEPARIN MARKET, BY INDICATION 89

  • 12.1 OVERVIEW 90
  • 12.2 DEEP VEIN THROMBOSIS 93
  • 12.3 PULMONARY EMBOLISM 93
  • 12.4 PERIPHERAL ARTERY DISEASE 93
  • 12.5 ARTERIAL THROMBOEMBOLISM 93
  • 12.6 MYOCARDIAL INFARCTION 93
  • 12.7 ATRIAL FIBRILLATION 94
  • 12.8 OTHERS 94

13 EUROPE & MIDDLE EAST HEPARIN MARKET, BY PACKAGING MATERIAL 95

  • 13.1 OVERVIEW 96
  • 13.2 GLASS 99
  • 13.3 PLASTIC 99

14 EUROPE & MIDDLE EAST HEPARIN MARKET, BY TYPE 100

  • 14.1 OVERVIEW 101
  • 14.2 GENERIC 104
  • 14.3 BRANDED 104

15 EUROPE & MIDDLE EAST HEPARIN MARKET, BY END USER 105

  • 15.1 OVERVIEW 106
  • 15.2 HOSPITALS 109
  • 15.3 CLINICS 110
  • 15.4 AMBULATORY SURGICAL CENTERS 111
  • 15.5 HOMECARE 111
  • 15.6 OTHERS 111

16 EUROPE & MIDDLE EAST HEPARIN MARKET, BY DISTRIBUTION CHANNEL 112

  • 16.1 OVERVIEW 113
  • 16.2 HOSPITAL PHARMACY 116
  • 16.3 RETAIL PHARMACY & DRUG STORE 116
  • 16.4 ONLINE PHARMACY 116
  • 16.5 OTHERS 116

17 EUROPE HEPARIN MARKET BY COUNTRY 117

  • 17.1 EUROPE 117
    • 17.1.1 GERMANY 127
    • 17.1.2 FRANCE 132
    • 17.1.3 U.K. 137
    • 17.1.4 ITALY 142
    • 17.1.5 SPAIN 147
    • 17.1.6 SWITZERLAND 152
    • 17.1.7 AUSTRIA 157
    • 17.1.8 POLAND 162
    • 17.1.9 TURKEY 167
    • 17.1.10 BELGIUM 172
    • 17.1.11 MALTA 176
    • 17.1.12 ROMANIA 180
    • 17.1.13 CZECH REPUBLIC 184
    • 17.1.14 IRELAND 189
    • 17.1.15 PORTUGAL 193
    • 17.1.16 NORWAY 197
    • 17.1.17 GREECE 201
    • 17.1.18 BULGARIA 205
    • 17.1.19 SLOVAKIA 209
    • 17.1.20 CYPRUS 214
    • 17.1.21 ESTONIA 218
    • 17.1.22 LATVIA 222
    • 17.1.23 CROATIA 227
    • 17.1.24 BOSNIA & HERZEGOVINA 232
    • 17.1.25 REST OF EUROPE 237
  • 17.2 MIDDLE EAST 238
    • 17.2.1 SAUDI ARABIA 239

18 EUROPE & MIDDLE EAST HEPARIN MARKET, COMPANY LANDSCAPE 244

  • 18.1 COMPANY SHARE ANALYSIS: EUROPE 244

19 SWOT ANALYSIS 245

20 COMPANY PROFILES 246

  • 20.1 LABORATORIOS FARMACEUTICOS ROVI SA 246
    • 20.1.1 COMPANY SNAPSHOT 246
    • 20.1.2 REVENUE ANALYSIS 246
    • 20.1.3 PRODUCT PORTFOLIO 247
    • 20.1.4 RECENT DEVELOPMENTS 248
  • 20.2 ITALFARMACO S.P.A. 249
    • 20.2.1 COMPANY SNAPSHOT 249
    • 20.2.2 PRODUCT PORTFOLIO 249
    • 20.2.3 RECENT DEVELOPMENT 249
  • 20.3 SANOFI 250
    • 20.3.1 COMPANY SNAPSHOT 250
    • 20.3.2 REVENUE ANALYSIS 250
    • 20.3.3 PRODUCT PORTFOLIO 251
    • 20.3.4 RECENT DEVELOPMENTS 251
  • 20.4 LEO PHARMA A/S 252
    • 20.4.1 COMPANY SNAPSHOT 252
    • 20.4.2 PRODUCT PORTFOLIO 252
    • 20.4.3 RECENT DEVELOPMENT 252
  • 20.5 MERCK KGAA 253
    • 20.5.1 COMPANY SNAPSHOT 253
    • 20.5.2 REVENUE ANALYSIS 253
    • 20.5.3 PRODUCT PORTFOLIO 254
    • 20.5.4 RECENT DEVELOPMENTS 254
  • 20.6 BIOIBERICA S.A.U. 255
    • 20.6.1 COMPANY SNAPSHOT 255
    • 20.6.2 PRODUCT PORTFOLIO 255
    • 20.6.3 RECENT DEVELOPMENT 257
  • 20.7 EISAI CO., LTD. 258
    • 20.7.1 COMPANY SNAPSHOT 258
    • 20.7.2 REVENUE ANALYSIS 258
    • 20.7.3 PRODUCT PORTFOLIO 259
    • 20.7.4 RECENT DEVELOPMENT 259
  • 20.8 HEPAC 260
    • 20.8.1 COMPANY SNAPSHOT 260
    • 20.8.2 PRODUCT PORTFOLIO 260
    • 20.8.3 RECENT DEVELOPMENT 260
  • 20.9 OPOCRIN S.P.A. 261
    • 20.9.1 COMPANY SNAPSHOT 261
    • 20.9.2 PRODUCT PORTFOLIO 261
    • 20.9.3 RECENT DEVELOPMENT 262

21 QUESTIONNAIRE 263

22 RELATED REPORTS 268

LIST OF TABLES

  • TABLE 1 EUROPE & MIDDLE EAST HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 66
  • TABLE 2 EUROPE & MIDDLE EAST LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 66
  • TABLE 3 EUROPE & MIDDLE EAST HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 72
  • TABLE 4 EUROPE & MIDDLE EAST HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 77
  • TABLE 5 EUROPE & MIDDLE EAST HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 83
  • TABLE 6 EUROPE & MIDDLE EAST HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 88
  • TABLE 7 EUROPE & MIDDLE EAST HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 93
  • TABLE 8 EUROPE & MIDDLE EAST HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 99
  • TABLE 9 EUROPE & MIDDLE EAST HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 104
  • TABLE 10 EUROPE & MIDDLE EAST HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 109
  • TABLE 11 EUROPE & MIDDLE EAST HOSPITALS HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 109
  • TABLE 12 EUROPE & MIDDLE EAST PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 109
  • TABLE 13 EUROPE & MIDDLE EAST PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 110
  • TABLE 14 EUROPE & MIDDLE EAST CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 110
  • TABLE 15 EUROPE & MIDDLE EAST AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 111
  • TABLE 16 EUROPE & MIDDLE EAST HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 111
  • TABLE 17 EUROPE & MIDDLE EAST HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 116
  • TABLE 18 EUROPE HEPARIN MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 120
  • TABLE 19 EUROPE HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 121
  • TABLE 20 EUROPE LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 121
  • TABLE 21 EUROPE HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 121
  • TABLE 22 EUROPE HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 122
  • TABLE 23 EUROPE HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 122
  • TABLE 24 EUROPE HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 122
  • TABLE 25 EUROPE HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 122
  • TABLE 26 EUROPE HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 123
  • TABLE 27 EUROPE HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 123
  • TABLE 28 EUROPE HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 123
  • TABLE 29 EUROPE HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 123
  • TABLE 30 EUROPE PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 123
  • TABLE 31 EUROPE PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 124
  • TABLE 32 EUROPE CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 125
  • TABLE 33 EUROPE AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 125
  • TABLE 34 EUROPE HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 125
  • TABLE 35 EUROPE HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 126
  • TABLE 36 GERMANY HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 127
  • TABLE 37 GERMANY LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 127
  • TABLE 38 GERMANY HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 127
  • TABLE 39 GERMANY HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 128
  • TABLE 40 GERMANY HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 128
  • TABLE 41 GERMANY HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 128
  • TABLE 42 GERMANY HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 129
  • TABLE 43 GERMANY HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 129
  • TABLE 44 GERMANY HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 129
  • TABLE 45 GERMANY HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 129
  • TABLE 46 GERMANY HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 130
  • TABLE 47 GERMANY PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 130
  • TABLE 48 GERMANY PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 130
  • TABLE 49 GERMANY CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 130
  • TABLE 50 GERMANY AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 131
  • TABLE 51 GERMANY HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 131
  • TABLE 52 GERMANY HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 131
  • TABLE 53 FRANCE HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 132
  • TABLE 54 FRANCE LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 132
  • TABLE 55 FRANCE HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 132
  • TABLE 56 FRANCE HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 132
  • TABLE 57 FRANCE HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 133
  • TABLE 58 FRANCE HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 133
  • TABLE 59 FRANCE HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 133
  • TABLE 60 FRANCE HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 133
  • TABLE 61 FRANCE HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 133
  • TABLE 62 FRANCE HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 134
  • TABLE 63 FRANCE HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 134
  • TABLE 64 FRANCE PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 134
  • TABLE 65 FRANCE PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 134
  • TABLE 66 FRANCE CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 135
  • TABLE 67 FRANCE AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 135
  • TABLE 68 FRANCE HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 135
  • TABLE 69 FRANCE HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 135
  • TABLE 70 U.K. HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 137
  • TABLE 71 U.K. LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 137
  • TABLE 72 U.K. HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 137
  • TABLE 73 U.K. HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 138
  • TABLE 74 U.K. HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 138
  • TABLE 75 U.K. HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 138
  • TABLE 76 U.K. HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 139
  • TABLE 77 U.K. HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 139
  • TABLE 78 U.K. HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 139
  • TABLE 79 U.K. HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 139
  • TABLE 80 U.K. HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 140
  • TABLE 81 U.K. PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 140
  • TABLE 82 U.K. PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 140
  • TABLE 83 U.K. CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 140
  • TABLE 84 U.K. AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 141
  • TABLE 85 U.K. HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 141
  • TABLE 86 U.K. HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 141
  • TABLE 87 ITALY HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 142
  • TABLE 88 ITALY LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 142
  • TABLE 89 ITALY HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 142
  • TABLE 90 ITALY HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 142
  • TABLE 91 ITALY HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 142
  • TABLE 92 ITALY HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 143
  • TABLE 93 ITALY HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 143
  • TABLE 94 ITALY HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 143
  • TABLE 95 ITALY HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 144
  • TABLE 96 ITALY HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 144
  • TABLE 97 ITALY HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 144
  • TABLE 98 ITALY PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 144
  • TABLE 99 ITALY PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 145
  • TABLE 100 ITALY CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 145
  • TABLE 101 ITALY AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 145
  • TABLE 102 ITALY HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 145
  • TABLE 103 ITALY HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 146
  • TABLE 104 SPAIN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 147
  • TABLE 105 SPAIN LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 147
  • TABLE 106 SPAIN HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 147
  • TABLE 107 SPAIN HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 147
  • TABLE 108 SPAIN HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 147
  • TABLE 109 SPAIN HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 148
  • TABLE 110 SPAIN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 148
  • TABLE 111 SPAIN HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 148
  • TABLE 112 SPAIN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 149
  • TABLE 113 SPAIN HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 149
  • TABLE 114 SPAIN HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 149
  • TABLE 115 SPAIN PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 149
  • TABLE 116 SPAIN PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 150
  • TABLE 117 SPAIN CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 150
  • TABLE 118 SPAIN AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 150
  • TABLE 119 SPAIN HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 150
  • TABLE 120 SPAIN HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 151
  • TABLE 121 SWITZERLAND HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 152
  • TABLE 122 SWITZERLAND LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 152
  • TABLE 123 SWITZERLAND HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 152
  • TABLE 124 SWITZERLAND HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 152
  • TABLE 125 SWITZERLAND HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 153
  • TABLE 126 SWITZERLAND HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 153
  • TABLE 127 SWITZERLAND HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 153
  • TABLE 128 SWITZERLAND HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 153
  • TABLE 129 SWITZERLAND HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 154
  • TABLE 130 SWITZERLAND HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 154
  • TABLE 131 SWITZERLAND HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 154
  • TABLE 132 SWITZERLAND PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 154
  • TABLE 133 SWITZERLAND PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 155
  • TABLE 134 SWITZERLAND CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 155
  • TABLE 135 SWITZERLAND AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 155
  • TABLE 136 SWITZERLAND HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 155
  • TABLE 137 SWITZERLAND HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 156
  • TABLE 138 AUSTRIA HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 157
  • TABLE 139 AUSTRIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 157
  • TABLE 140 AUSTRIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 157
  • TABLE 141 AUSTRIA HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 157
  • TABLE 142 AUSTRIA HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 157
  • TABLE 143 AUSTRIA HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 158
  • TABLE 144 AUSTRIA HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 158
  • TABLE 145 AUSTRIA HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 158
  • TABLE 146 AUSTRIA HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 159
  • TABLE 147 AUSTRIA HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 159
  • TABLE 148 AUSTRIA HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 159
  • TABLE 149 AUSTRIA PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 159
  • TABLE 150 AUSTRIA PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 160
  • TABLE 151 AUSTRIA CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 160
  • TABLE 152 AUSTRIA AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 160
  • TABLE 153 AUSTRIA HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 160
  • TABLE 154 AUSTRIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 161
  • TABLE 155 POLAND HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 162
  • TABLE 156 POLAND LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 162
  • TABLE 157 POLAND HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 162
  • TABLE 158 POLAND HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 162
  • TABLE 159 POLAND HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 162
  • TABLE 160 POLAND HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 163
  • TABLE 161 POLAND HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 163
  • TABLE 162 POLAND HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 163
  • TABLE 163 POLAND HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 164
  • TABLE 164 POLAND HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 164
  • TABLE 165 POLAND HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 164
  • TABLE 166 POLAND PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 164
  • TABLE 167 POLAND PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 165
  • TABLE 168 POLAND CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 165
  • TABLE 169 POLAND AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 165
  • TABLE 170 POLAND HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 165
  • TABLE 171 POLAND HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 166
  • TABLE 172 TURKEY HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 167
  • TABLE 173 TURKEY LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 167
  • TABLE 174 TURKEY HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 167
  • TABLE 175 TURKEY HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 167
  • TABLE 176 TURKEY HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 168
  • TABLE 177 TURKEY HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 168
  • TABLE 178 TURKEY HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 168
  • TABLE 179 TURKEY HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 168
  • TABLE 180 TURKEY HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 169
  • TABLE 181 TURKEY HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 169
  • TABLE 182 TURKEY HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 169
  • TABLE 183 TURKEY PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 169
  • TABLE 184 TURKEY PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 170
  • TABLE 185 TURKEY CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 170
  • TABLE 186 TURKEY AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 170
  • TABLE 187 TURKEY HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 170
  • TABLE 188 TURKEY HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 171
  • TABLE 189 BELGIUM HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 172
  • TABLE 190 BELGIUM LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 172
  • TABLE 191 BELGIUM HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 172
  • TABLE 192 BELGIUM HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 172
  • TABLE 193 BELGIUM HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 173
  • TABLE 194 BELGIUM HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 173
  • TABLE 195 BELGIUM HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 173
  • TABLE 196 BELGIUM HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 173
  • TABLE 197 BELGIUM HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 173
  • TABLE 198 BELGIUM HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 174
  • TABLE 199 BELGIUM HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 174
  • TABLE 200 BELGIUM PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 174
  • TABLE 201 BELGIUM PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 174
  • TABLE 202 BELGIUM CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 175
  • TABLE 203 BELGIUM AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 175
  • TABLE 204 BELGIUM HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 175
  • TABLE 205 BELGIUM HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 175
  • TABLE 206 MALTA HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 176
  • TABLE 207 MALTA LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 176
  • TABLE 208 MALTA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 176
  • TABLE 209 MALTA HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 176
  • TABLE 210 MALTA HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 177
  • TABLE 211 MALTA HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 177
  • TABLE 212 MALTA HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 177
  • TABLE 213 MALTA HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 177
  • TABLE 214 MALTA HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 177
  • TABLE 215 MALTA HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 178
  • TABLE 216 MALTA HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 178
  • TABLE 217 MALTA PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 178
  • TABLE 218 MALTA PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 178
  • TABLE 219 MALTA CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 179
  • TABLE 220 MALTA AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 179
  • TABLE 221 MALTA HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 179
  • TABLE 222 MALTA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 179
  • TABLE 223 ROMANIA HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 180
  • TABLE 224 ROMANIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 180
  • TABLE 225 ROMANIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 180
  • TABLE 226 ROMANIA HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 180
  • TABLE 227 ROMANIA HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 181
  • TABLE 228 ROMANIA HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 181
  • TABLE 229 ROMANIA HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 181
  • TABLE 230 ROMANIA HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 181
  • TABLE 231 ROMANIA HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 181
  • TABLE 232 ROMANIA HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 182
  • TABLE 233 ROMANIA HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 182
  • TABLE 234 ROMANIA PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 182
  • TABLE 235 ROMANIA PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 182
  • TABLE 236 ROMANIA CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 183
  • TABLE 237 ROMANIA AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 183
  • TABLE 238 ROMANIA HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 183
  • TABLE 239 ROMANIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 183
  • TABLE 240 CZECH REPUBLIC HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 184
  • TABLE 241 CZECH REPUBLIC LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 184
  • TABLE 242 CZECH REPUBLIC HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 184
  • TABLE 243 CZECH REPUBLIC HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 184
  • TABLE 244 CZECH REPUBLIC HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 185
  • TABLE 245 CZECH REPUBLIC HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 185
  • TABLE 246 CZECH REPUBLIC HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 185
  • TABLE 247 CZECH REPUBLIC HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 185
  • TABLE 248 CZECH REPUBLIC HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 186
  • TABLE 249 CZECH REPUBLIC HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 186
  • TABLE 250 CZECH REPUBLIC HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 186
  • TABLE 251 CZECH REPUBLIC PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 186
  • TABLE 252 CZECH REPUBLIC PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 187
  • TABLE 253 CZECH REPUBLIC CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 187
  • TABLE 254 CZECH REPUBLIC AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 187
  • TABLE 255 CZECH REPUBLIC HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 187
  • TABLE 256 CZECH REPUBLIC HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 188
  • TABLE 257 IRELAND HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 189
  • TABLE 258 IRELAND LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 189
  • TABLE 259 IRELAND HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 189
  • TABLE 260 IRELAND HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 189
  • TABLE 261 IRELAND HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 190
  • TABLE 262 IRELAND HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 190
  • TABLE 263 IRELAND HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 190
  • TABLE 264 IRELAND HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 190
  • TABLE 265 IRELAND HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 190
  • TABLE 266 IRELAND HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 191
  • TABLE 267 IRELAND HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 191
  • TABLE 268 IRELAND PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 191
  • TABLE 269 IRELAND PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 191
  • TABLE 270 IRELAND CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 192
  • TABLE 271 IRELAND AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 192
  • TABLE 272 IRELAND HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 192
  • TABLE 273 IRELAND HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 192
  • TABLE 274 PORTUGAL HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 193
  • TABLE 275 PORTUGAL LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 193
  • TABLE 276 PORTUGAL HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 193
  • TABLE 277 PORTUGAL HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 193
  • TABLE 278 PORTUGAL HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 194
  • TABLE 279 PORTUGAL HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 194
  • TABLE 280 PORTUGAL HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 194
  • TABLE 281 PORTUGAL HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 194
  • TABLE 282 PORTUGAL HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 194
  • TABLE 283 PORTUGAL HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 195
  • TABLE 284 PORTUGAL HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 195
  • TABLE 285 PORTUGAL PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 195
  • TABLE 286 PORTUGAL PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 195
  • TABLE 287 PORTUGAL CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 196
  • TABLE 288 PORTUGAL AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 196
  • TABLE 289 PORTUGAL HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 196
  • TABLE 290 PORTUGAL HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 196
  • TABLE 291 NORWAY HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 197
  • TABLE 292 NORWAY LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 197
  • TABLE 293 NORWAY HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 197
  • TABLE 294 NORWAY HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 197
  • TABLE 295 NORWAY HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 198
  • TABLE 296 NORWAY HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 198
  • TABLE 297 NORWAY HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 198
  • TABLE 298 NORWAY HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 198
  • TABLE 299 NORWAY HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 198
  • TABLE 300 NORWAY HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 199
  • TABLE 301 NORWAY HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 199
  • TABLE 302 NORWAY PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 199
  • TABLE 303 NORWAY PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 199
  • TABLE 304 NORWAY CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 200
  • TABLE 305 NORWAY AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 200
  • TABLE 306 NORWAY HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 200
  • TABLE 307 NORWAY HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 200
  • TABLE 308 GREECE HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 201
  • TABLE 309 GREECE LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 201
  • TABLE 310 GREECE HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 201
  • TABLE 311 GREECE HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 201
  • TABLE 312 GREECE HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 202
  • TABLE 313 GREECE HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 202
  • TABLE 314 GREECE HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 202
  • TABLE 315 GREECE HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 202
  • TABLE 316 GREECE HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 202
  • TABLE 317 GREECE HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 203
  • TABLE 318 GREECE HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 203
  • TABLE 319 GREECE PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 203
  • TABLE 320 GREECE PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 203
  • TABLE 321 GREECE CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 204
  • TABLE 322 GREECE AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 204
  • TABLE 323 GREECE HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 204
  • TABLE 324 GREECE HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 204
  • TABLE 325 BULGARIA HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 205
  • TABLE 326 BULGARIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 205
  • TABLE 327 BULGARIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 205
  • TABLE 328 BULGARIA HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 205
  • TABLE 329 BULGARIA HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 206
  • TABLE 330 BULGARIA HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 206
  • TABLE 331 BULGARIA HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 206
  • TABLE 332 BULGARIA HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 206
  • TABLE 333 BULGARIA HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 206
  • TABLE 334 BULGARIA HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 207
  • TABLE 335 BULGARIA HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 207
  • TABLE 336 BULGARIA PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 207
  • TABLE 337 BULGARIA PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 207
  • TABLE 338 BULGARIA CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 208
  • TABLE 339 BULGARIA AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 208
  • TABLE 340 BULGARIA HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 208
  • TABLE 341 BULGARIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 208
  • TABLE 342 SLOVAKIA HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 209
  • TABLE 343 SLOVAKIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 209
  • TABLE 344 SLOVAKIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 209
  • TABLE 345 SLOVAKIA HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 209
  • TABLE 346 SLOVAKIA HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 210
  • TABLE 347 SLOVAKIA HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 210
  • TABLE 348 SLOVAKIA HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 210
  • TABLE 349 SLOVAKIA HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 210
  • TABLE 350 SLOVAKIA HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 211
  • TABLE 351 SLOVAKIA HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 211
  • TABLE 352 SLOVAKIA HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 211
  • TABLE 353 SLOVAKIA PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 211
  • TABLE 354 SLOVAKIA PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 212
  • TABLE 355 SLOVAKIA CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 212
  • TABLE 356 SLOVAKIA AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 212
  • TABLE 357 SLOVAKIA HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 213
  • TABLE 358 SLOVAKIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 213
  • TABLE 359 CYPRUS HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 214
  • TABLE 360 CYPRUS LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 214
  • TABLE 361 CYPRUS HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 214
  • TABLE 362 CYPRUS HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 214
  • TABLE 363 CYPRUS HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 215
  • TABLE 364 CYPRUS HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 215
  • TABLE 365 CYPRUS HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 215
  • TABLE 366 CYPRUS HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 215
  • TABLE 367 CYPRUS HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 215
  • TABLE 368 CYPRUS HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 216
  • TABLE 369 CYPRUS HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 216
  • TABLE 370 CYPRUS PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 216
  • TABLE 371 CYPRUS PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 216
  • TABLE 372 CYPRUS CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 217
  • TABLE 373 CYPRUS AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 217
  • TABLE 374 CYPRUS HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 217
  • TABLE 375 CYPRUS HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 217
  • TABLE 376 ESTONIA HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 218
  • TABLE 377 ESTONIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 218
  • TABLE 378 ESTONIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 218
  • TABLE 379 ESTONIA HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 218
  • TABLE 380 ESTONIA HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 219
  • TABLE 381 ESTONIA HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 219
  • TABLE 382 ESTONIA HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 219
  • TABLE 383 ESTONIA HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 219
  • TABLE 384 ESTONIA HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 219
  • TABLE 385 ESTONIA HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 220
  • TABLE 386 ESTONIA HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 220
  • TABLE 387 ESTONIA PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 220
  • TABLE 388 ESTONIA PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 220
  • TABLE 389 ESTONIA CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 221
  • TABLE 390 ESTONIA AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 221
  • TABLE 391 ESTONIA HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 221
  • TABLE 392 ESTONIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 221
  • TABLE 393 LATVIA HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 222
  • TABLE 394 LATVIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 222
  • TABLE 395 LATVIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 222
  • TABLE 396 LATVIA HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 222
  • TABLE 397 LATVIA HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 223
  • TABLE 398 LATVIA HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 223
  • TABLE 399 LATVIA HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 223
  • TABLE 400 LATVIA HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 223
  • TABLE 401 LATVIA HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 223
  • TABLE 402 LATVIA HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 224
  • TABLE 403 LATVIA HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 224
  • TABLE 404 LATVIA PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 224
  • TABLE 405 LATVIA PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 224
  • TABLE 406 LATVIA CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 225
  • TABLE 407 LATVIA AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 225
  • TABLE 408 LATVIA HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 225
  • TABLE 409 LATVIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 226
  • TABLE 410 CROATIA HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 227
  • TABLE 411 CROATIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 227
  • TABLE 412 CROATIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 227
  • TABLE 413 CROATIA HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 227
  • TABLE 414 CROATIA HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 228
  • TABLE 415 CROATIA HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 228
  • TABLE 416 CROATIA HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 228
  • TABLE 417 CROATIA HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 228
  • TABLE 418 CROATIA HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 228
  • TABLE 419 CROATIA HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 229
  • TABLE 420 CROATIA HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 229
  • TABLE 421 CROATIA PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 229
  • TABLE 422 CROATIA PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 229
  • TABLE 423 CROATIA CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 230
  • TABLE 424 CROATIA AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 230
  • TABLE 425 CROATIA HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 230
  • TABLE 426 CROATIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 231
  • TABLE 427 BOSNIA & HERZEGOVINA HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 232
  • TABLE 428 BOSNIA & HERZEGOVINA LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 232
  • TABLE 429 BOSNIA & HERZEGOVINA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 232
  • TABLE 430 BOSNIA & HERZEGOVINA HEPARIN MARKET, BY PACKAGING, 2022-2031 (USD THOUSAND) 232
  • TABLE 431 BOSNIA & HERZEGOVINA HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 233
  • TABLE 432 BOSNIA & HERZEGOVINA HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 233
  • TABLE 433 BOSNIA & HERZEGOVINA HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 233
  • TABLE 434 BOSNIA & HERZEGOVINA HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 233
  • TABLE 435 BOSNIA & HERZEGOVINA HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 234
  • TABLE 436 BOSNIA & HERZEGOVINA HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 234
  • TABLE 437 BOSNIA & HERZEGOVINA HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 234
  • TABLE 438 BOSNIA & HERZEGOVINA PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 234
  • TABLE 439 BOSNIA & HERZEGOVINA PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 235
  • TABLE 440 BOSNIA & HERZEGOVINA CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 235
  • TABLE 441 BOSNIA & HERZEGOVINA AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 235
  • TABLE 442 BOSNIA & HERZEGOVINA HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 236
  • TABLE 443 BOSNIA & HERZEGOVINA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 236
  • TABLE 444 REST OF EUROPE HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 237
  • TABLE 445 MIDDLE EAST HEPARIN MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 238
  • TABLE 446 SAUDI ARABIA HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 239
  • TABLE 447 SAUDI ARABIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 239
  • TABLE 448 SAUDI ARABIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2022-2031 (USD THOUSAND) 239
  • TABLE 449 SAUDI ARABIA HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 240
  • TABLE 450 SAUDI ARABIA HEPARIN MARKET, BY SOURCE, 2022-2031 (USD THOUSAND) 240
  • TABLE 451 SAUDI ARABIA HEPARIN MARKET, BY INDICATION, 2022-2031 (USD THOUSAND) 240
  • TABLE 452 SAUDI ARABIA HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 241
  • TABLE 453 SAUDI ARABIA HEPARIN MARKET, BY CONTAINER TYPE, 2022-2031 (USD THOUSAND) 241
  • TABLE 454 SAUDI ARABIA HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 241
  • TABLE 455 SAUDI ARABIA HEPARIN MARKET, BY END USER, 2022-2031 (USD THOUSAND) 241
  • TABLE 456 SAUDI ARABIA HOSPITALS IN HEPARIN MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 242
  • TABLE 457 SAUDI ARABIA PUBLIC IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 242
  • TABLE 458 SAUDI ARABIA PRIVATE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 242
  • TABLE 459 SAUDI ARABIA CLINICS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 242
  • TABLE 460 SAUDI ARABIA AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 243
  • TABLE 461 SAUDI ARABIA HOMECARE IN HEPARIN MARKET, BY PACKAGING MATERIAL, 2022-2031 (USD THOUSAND) 243
  • TABLE 462 SAUDI ARABIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 243

LIST OF FIGURES

  • FIGURE 1 EUROPE AND MIDDLE EAST HEPARIN MARKET: SEGMENTATION 35
  • FIGURE 2 EUROPE AND MIDDLE EAST HEPARIN MARKET: DATA TRIANGULATION 37
  • FIGURE 3 EUROPE AND MIDDLE EAST HEPARIN MARKET: DROC ANALYSIS 38
  • FIGURE 4 EUROPE AND MIDDLE EAST HEPARIN MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS 39
  • FIGURE 5 EUROPE AND MIDDLE EAST HEPARIN MARKET: COMPANY RESEARCH ANALYSIS 39
  • FIGURE 6 EUROPE AND MIDDLE EAST HEPARIN MARKET: INTERVIEW DEMOGRAPHICS 40
  • FIGURE 7 EUROPE AND MIDDLE EAST HEPARIN MARKET: MARKET END USER COVERAGE GRID 42
  • FIGURE 8 EUROPE AND MIDDLE EAST HEPARIN MARKET: DBMR MARKET POSITION GRID 43
  • FIGURE 9 EUROPE AND MIDDLE EAST HEPARIN MARKET: VENDOR SHARE ANALYSIS 44
  • FIGURE 10 EUROPE AND MIDDLE EAST HEPARIN MARKET: SEGMENTATION 48
  • FIGURE 11 RISING PREVALENCE OF VENOUS THROMBOEMBOLISM AND PULMONARY EMBOLISM IS EXPECTED TO DRIVE THE GROWTH OF THE EUROPE AND MIDDLE EAST HEPARIN MARKET FROM 2024 TO 2034 49
  • FIGURE 12 LOW MOLECULAR WEIGHT HEPARIN (LMWH)SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE AND MIDDLE EAST HEPARIN MARKET IN 2024 TO 2031 49
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF EUROPE & MIDDLE EAST HEPARIN MARKET 55
  • FIGURE 14 EUROPE & MIDDLE EAST HEPARIN MARKET: BY PRODUCT TYPE, 2022 63
  • FIGURE 15 EUROPE & MIDDLE EAST HEPARIN MARKET: BY PRODUCT TYPE, 2024-2031 (USD THOUSAND) 64
  • FIGURE 16 EUROPE & MIDDLE EAST HEPARIN MARKET: BY PRODUCT TYPE, CAGR (2024-2031) 64
  • FIGURE 17 EUROPE & MIDDLE EAST HEPARIN MARKET: BY PRODUCT TYPE, LIFELINE CURVE 65
  • FIGURE 18 EUROPE & MIDDLE EAST HEPARIN MARKET: BY MODE OF ADMINISTRATION, 2022 69
  • FIGURE 19 EUROPE & MIDDLE EAST HEPARIN MARKET: BY MODE OF ADMINISTRATION, 2024-2031 (USD THOUSAND) 70
  • FIGURE 20 EUROPE & MIDDLE EAST HEPARIN MARKET: BY MODE OF ADMINISTRATION, CAGR (2024-2031) 70
  • FIGURE 21 EUROPE & MIDDLE EAST HEPARIN MARKET: BY MODE OF ADMINISTRATION, LIFELINE CURVE 71
  • FIGURE 22 EUROPE & MIDDLE EAST HEPARIN MARKET: BY PACKAGING, 2022 74
  • FIGURE 23 EUROPE & MIDDLE EAST HEPARIN MARKET: BY PACKAGING, 2024-2031 (USD THOUSAND) 75
  • FIGURE 24 EUROPE & MIDDLE EAST HEPARIN MARKET: BY PACKAGING, CAGR (2024-2031) 75
  • FIGURE 25 EUROPE & MIDDLE EAST HEPARIN MARKET: BY PACKAGING, LIFELINE CURVE 76
  • FIGURE 26 EUROPE & MIDDLE EAST HEPARIN MARKET: BY SOURCE, 2022 80
  • FIGURE 27 EUROPE & MIDDLE EAST HEPARIN MARKET: BY SOURCE, 2024-2031 (USD THOUSAND) 81
  • FIGURE 28 EUROPE & MIDDLE EAST HEPARIN MARKET: BY SOURCE, CAGR (2024-2031) 81
  • FIGURE 29 EUROPE & MIDDLE EAST HEPARIN MARKET: BY SOURCE, LIFELINE CURVE 82
  • FIGURE 30 EUROPE & MIDDLE EAST HEPARIN MARKET: BY CONTAINER TYPE, 2022 85
  • FIGURE 31 EUROPE & MIDDLE EAST HEPARIN MARKET: BY CONTAINER TYPE, 2024-2031 (USD THOUSAND) 86
  • FIGURE 32 EUROPE & MIDDLE EAST HEPARIN MARKET: BY CONTAINER TYPE, CAGR (2024-2031) 86
  • FIGURE 33 EUROPE & MIDDLE EAST HEPARIN MARKET: BY CONTAINER TYPE, LIFELINE CURVE 87
  • FIGURE 34 EUROPE & MIDDLE EAST HEPARIN MARKET: BY INDICATION, 2022 90
  • FIGURE 35 EUROPE & MIDDLE EAST HEPARIN MARKET: BY INDICATION, 2024-2031 (USD THOUSAND) 91
  • FIGURE 36 EUROPE & MIDDLE EAST HEPARIN MARKET: BY INDICATION, CAGR (2024-2031) 91
  • FIGURE 37 EUROPE & MIDDLE EAST HEPARIN MARKET: BY INDICATION, LIFELINE CURVE 92
  • FIGURE 38 EUROPE & MIDDLE EAST HEPARIN MARKET: BY PACKAGING MATERIAL, 2022 96
  • FIGURE 39 EUROPE & MIDDLE EAST HEPARIN MARKET: BY PACKAGING MATERIAL, 2024-2031 (USD THOUSAND) 97
  • FIGURE 40 EUROPE & MIDDLE EAST HEPARIN MARKET: BY PACKAGING MATERIAL, CAGR (2024-2031) 97
  • FIGURE 41 EUROPE & MIDDLE EAST HEPARIN MARKET: BY PACKAGING MATERIAL, LIFELINE CURVE 98
  • FIGURE 42 EUROPE & MIDDLE EAST HEPARIN MARKET: BY TYPE, 2022 101
  • FIGURE 43 EUROPE & MIDDLE EAST HEPARIN MARKET: BY TYPE, 2024-2031 (USD THOUSAND) 102
  • FIGURE 44 EUROPE & MIDDLE EAST HEPARIN MARKET: BY TYPE, CAGR (2024-2031) 102
  • FIGURE 45 EUROPE & MIDDLE EAST HEPARIN MARKET: BY TYPE, LIFELINE CURVE 103
  • FIGURE 46 EUROPE & MIDDLE EAST HEPARIN MARKET: BY END USER, 2022 106
  • FIGURE 47 EUROPE & MIDDLE EAST HEPARIN MARKET: BY END USER, 2024-2031 (USD THOUSAND) 107
  • FIGURE 48 EUROPE & MIDDLE EAST HEPARIN MARKET: BY END USER, CAGR (2024-2031) 107
  • FIGURE 49 EUROPE & MIDDLE EAST HEPARIN MARKET: BY END USER, LIFELINE CURVE 108
  • FIGURE 50 EUROPE & MIDDLE EAST HEPARIN MARKET: BY DISTRIBUTION CHANNEL, 2022 113
  • FIGURE 51 EUROPE & MIDDLE EAST HEPARIN MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND) 114
  • FIGURE 52 EUROPE & MIDDLE EAST HEPARIN MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031) 114
  • FIGURE 53 EUROPE & MIDDLE EAST HEPARIN MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 115
  • FIGURE 54 EUROPE & MIDDLE EAST HEPARIN MARKET: COMPANY SHARE 2023 (%) 244
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!